DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
According to paper filed on Feb. 2, 2026, the applicants have canceled claims 62, 72 and 73 and furthermore, have amended claims 34, 38-44, 47-57, 60-61, 64-69 and 78-80.
Claims 34, 38-44, 47-57, 60-61, 64-69 and 74-80 are pending in the application.
Response to Arguments
Applicant's arguments filed on Fe have been fully considered but they are not persuasive regarding enablement rejection of claims 69 and 74-77 and provisional ODP rejection. The applicants have amended claims to overcome all other rejections. Regarding enablement rejection of claims 69 and 74-77, the applicants did not address this rejection at all in their response or submitted NPL documents in support of treating all these disease conditions listed in instant claim 69.
Regarding provisional ODP rejection, the applicants did not submit terminal disclaimer. However, once the enablement rejection is addressed and the instant application is ready to be allowed, provisional ODP rejection will be withdrawn if application 18/685,523 is still pending.
Conclusion
The enablement rejection of claims 69 and 74-77 under 35 U.S.C. 112, 1st paragraph is maintained.
The provisional ODP rejection of claims 34, 38-44, 47-57, 60-61, 64-69 and 74-80 overclaims of application 18/685,523 is maintained.
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHARANJIT AULAKH whose telephone number is (571)272-0678. The examiner can normally be reached Monday-Friday 7:00-3:30.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Clinton A Brooks can be reached at 571-270-7682. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CHARANJIT AULAKH/ Primary Examiner, Art Unit 1621